GMO Financial Gate, Inc.

As of March 31, 2026, GMO Financial Gate, Inc. carries a market capitalization of 42.93B, placing it among publicly traded companies globally. Its enterprise value stands at 42.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

GMO Financial Gate, Inc.'s next confirmed earnings release is scheduled for November 12, 2026.

As of March 31, 2026, GMO Financial Gate, Inc. has 8.26M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, GMO Financial Gate, Inc. maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, GMO Financial Gate, Inc.'s stock has gained approximately 4.78% over the past 52 weeks. The 50-day moving average sits at 6,292.40, while the 200-day moving average is 5,874.95.

As of March 31, 2026, GMO Financial Gate, Inc. holds 5.17B in cash and equivalents against 4.40B in total debt, resulting in a net debt position of -758.42M. Total book value stands at 6.49B, with working capital of 5.44B providing operational flexibility.

GMO Financial Gate, Inc.'s most recent stock split took place on January 13, 2023 with a 1:2 split ratio.